Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US clearance for wound debridement device:

This article was originally published in Clinica

Executive Summary

HydroCision has received US FDA 510(k) clearance for its rapid, fluidjet-based wound debridement system. TraumaJet can be used to remove contamination, such as dirt and grease, from a traumatic wound as well as dead or damaged tissue. The system creates its own suction at the site without the need for a connection to an external source and minimises the risk of spreading bacteria or contamination further into a wound said the Andover, Massachusetts-based company. The system will be marketed worldwide by Orthofix International.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT076135

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel